The objective of the aforesaid study was to assess the frequency of Epistaxis in IDPs who migrated from North Waziristan agency during military operation "Zarb-E-Azab". This study was conducted in ENT department, DHQ teaching hospital Bannu from august 2014 to May 2015. The inclusion criteria was acute epistaxis occurred due to any reason. The exclusion criteria were the natural blood stoppage. The data was collected based on age, gender, causes, type, treatment success rate and the actual need for hospitalization of victims. The results of this study showed that out of 121 patients during 10 months, 72% (87.12) were male patients while rest of the patients i.e. 28% (33.88) were female. The prevalence of epistaxis in male was higher than the female patients. The average age group was 37 years. During the study, the most prevailing cause for the epistaxis was trauma (50.20%) in youngsters which was followed by hypertension (29.30%) in adults. Anterior epistaxis was around 58.20% while posterior one was 22.11%. AgNO 3 cautry (56.45%) was the commonest treatment regimen followed by anterior nasal packing (32.78%). We achieved a success rate of 30% for AgNO 3 cautry and 47% for anterior nasal packing. In cases of acute/persistent epistaxis, where first-aid events have failed, and providing a bleeding vessel is visible, cautery with a silver nitrate tipped stick is the treatment of choice. However, where there is profuse bleeding from larger nasal arteries or veins, difficulty is often experienced in curtailing the blood flow, and commonly one must resort to electro cautry or tamponade by balloon or packing. Modifying the technique of silver nitrate cautry will result in universal success.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.